soul trial oral semaglutide cardiovascular outcomes results 2024 nejm (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine Oral Semaglutide Lowers Cardiovascular Events

Many report that being on GLP-1 drugs reduces their level of food noise. With fewer intrusive thoughts about food, its easier to make balanced choices

Glutathione therapy: from prodrugs to genes

Aliment Pharmacol Ther 2020;51:603-11

Be sure to inform your doctor if you have a history of: Kidney disease Liver problems Severe gastrointestinal disease Partner with Healthon for Personalized Care Starting a medical weight-loss journey is easier with expert support

Nutritional Support Eat a balanced diet with sufficient protein to provide the amino acids required to build collagen and elastin

Sometimes a medication prescribed primarily for diabetes, but containing the same active ingredient as a weight loss drug, may be covered